PDSB
Price
$5.54
Change
+$0.12 (+2.21%)
Updated
Feb 26, 6:59 PM EST
30 days until earnings call
VCYT
Price
$23.56
Change
+$1.38 (+6.22%)
Updated
Feb 26, 6:59 PM EST
63 days until earnings call
Ad is loading...

Compare predictions PDSB vs VCYT

Header iconPDSB vs VCYT Comparison
Open Charts PDSB vs VCYTBanner chart's image
PDS Biotechnology
Price$5.54
Change+$0.12 (+2.21%)
Volume$391.56K
CapitalizationN/A
Veracyte
Price$23.56
Change+$1.38 (+6.22%)
Volume$602.07K
CapitalizationN/A
View a ticker or compare two or three
PDSB vs VCYT Comparison Chart

Loading...

PDSBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PDSB vs. VCYT commentary
Feb 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Buy and VCYT is a Hold.

COMPARISON
Comparison
Feb 27, 2024
Stock price -- (PDSB: $5.54 vs. VCYT: $23.56)
Brand notoriety: PDSB and VCYT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 109% vs. VCYT: 193%
Market capitalization -- PDSB: $168.6M vs. VCYT: $1.62B
PDSB [@Biotechnology] is valued at $168.6M. VCYT’s [@Biotechnology] market capitalization is $1.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 1 green FA rating(s).

  • PDSB’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 1 green, 4 red.
According to our system of comparison, VCYT is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 6 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • PDSB’s TA Score: 6 bullish, 4 bearish.
  • VCYT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than VCYT.

Price Growth

PDSB (@Biotechnology) experienced а +2.59% price change this week, while VCYT (@Biotechnology) price change was -4.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +16.73%, and the average quarterly price growth was +41.60%.

Reported Earning Dates

PDSB is expected to report earnings on May 14, 2024.

VCYT is expected to report earnings on Apr 30, 2024.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PDSB with price predictions.
OPEN
A.I.dvisor published
a Summary for VCYT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VCYT($1.62B) has a higher market cap than PDSB($169M). PDSB YTD gains are higher at: 11.469 vs. VCYT (-14.358). VCYT has higher annual earnings (EBITDA): -22.16M vs. PDSB (-48.62M). VCYT has more cash in the bank: 202M vs. PDSB (54.3M). VCYT has less debt than PDSB: VCYT (13.7M) vs PDSB (23.6M). VCYT has higher revenues than PDSB: VCYT (343M) vs PDSB (0).
PDSBVCYTPDSB / VCYT
Capitalization169M1.62B10%
EBITDA-48.62M-22.16M219%
Gain YTD11.469-14.358-80%
P/E RatioN/AN/A-
Revenue0343M-
Total Cash54.3M202M27%
Total Debt23.6M13.7M172%
FUNDAMENTALS RATINGS
PDSB vs VCYT: Fundamental Ratings
PDSB
VCYT
OUTLOOK RATING
1..100
1762
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
5972
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (27) in the Biotechnology industry is in the same range as PDSB (56) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to PDSB’s over the last 12 months.

VCYT's Profit vs Risk Rating (88) in the Biotechnology industry is in the same range as PDSB (100) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to PDSB’s over the last 12 months.

VCYT's SMR Rating (91) in the Biotechnology industry is in the same range as PDSB (99) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to PDSB’s over the last 12 months.

PDSB's Price Growth Rating (59) in the Pharmaceuticals Major industry is in the same range as VCYT (72) in the Biotechnology industry. This means that PDSB’s stock grew similarly to VCYT’s over the last 12 months.

PDSB's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as VCYT (100) in the Biotechnology industry. This means that PDSB’s stock grew similarly to VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDSBVCYT
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 20 days ago
88%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
PDSBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AYBLX10.71N/A
N/A
Pioneer Balanced ESG Y
TNWCX21.15-0.02
-0.09%
TIAA-CREF Social Choice LwCrbn Eq Instl
FSZIX8.41-0.01
-0.12%
Fidelity Advisor Sustainable EM Eq I
JACNX26.90-0.09
-0.33%
Janus Henderson Contrarian D
TVOCX32.56-0.13
-0.40%
Touchstone Small Cap Value C

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+2.21%
AXON - PDSB
43%
Loosely correlated
+0.35%
INZY - PDSB
41%
Loosely correlated
+7.01%
VCYT - PDSB
39%
Loosely correlated
+6.22%
MDGL - PDSB
38%
Loosely correlated
-1.68%
LGND - PDSB
38%
Loosely correlated
-1.91%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+6.22%
NTLA - VCYT
71%
Closely correlated
+5.98%
SRNEQ - VCYT
62%
Loosely correlated
-71.72%
BEAM - VCYT
60%
Loosely correlated
+5.33%
VCEL - VCYT
60%
Loosely correlated
+1.61%
DNA - VCYT
59%
Loosely correlated
+6.06%
More